Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

Outcomes of Older Patients (≥60 years) with New-Onset Idiopathic Nephrotic Syndrome Receiving Immunosuppressive Regimen: A Multicentre Study of 116 Patients

Because of its rarity, renal presentation and outcomes of idiopathic nephrotic syndrome (INS; minimal changes disease or focal and segmental glomerulosclerosis) has poorly been described in elderly patients, precluding an individualized therapy procedure. Whether immunosuppressive regimens formerly...

Full description

Bibliographic Details
Main Authors: Eloïse Colliou, Alexandre Karras, Jean-Jacques Boffa, David Ribes, Cyril Garrouste, Moglie Le Quintrec, Eric Daugas, Antoine Huart, Didier Ducloux, Aurélie Hummel, Inès Ferrandiz, Nathalie Demoulin, Noémie Jourde-Chiche, Dominique Chauveau, Vincent Audard, Stanislas Faguer
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Journal of Clinical Medicine
Subjects:
minimal change disease
focal segmental glomerulosclerosis
older patients
rituximab
infection
Online Access:http://www.mdpi.com/2077-0383/8/3/298

Internet

http://www.mdpi.com/2077-0383/8/3/298

Similar Items